138 related articles for article (PubMed ID: 4925011)
1. Relationship of long-acting thyroid stimulator to pretibial myxedema.
Schermer DR; Roenigk HH; Schumacher OP; McKenzie JM
Arch Dermatol; 1970 Jul; 102(1):62-7. PubMed ID: 4925011
[No Abstract] [Full Text] [Related]
2. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
From E; Diederichsen H; Heydenreich G; Nielsen OS
Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
[No Abstract] [Full Text] [Related]
3. ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.
KRISS JP; PLESHAKOV V; CHIEN JR
J Clin Endocrinol Metab; 1964 Oct; 24():1005-28. PubMed ID: 14228525
[No Abstract] [Full Text] [Related]
4. Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema.
Kuzuya N; DeGroot LJ
J Endocrinol Invest; 1982; 5(6):373-8. PubMed ID: 6132943
[TBL] [Abstract][Full Text] [Related]
5. [Myxedema tuberosum atypicum (Jadassohn-Doesserkker, 1916) in the clinical picture of the myxodermias and in the normal course of Graves-Basedow's disease].
Rabello FE; Reis VL; Marques AS; Tendrich M; Cordeiro JG
Med Cutan Ibero Lat Am; 1983; 11(6):399-412. PubMed ID: 6366397
[TBL] [Abstract][Full Text] [Related]
6. Pretibial myxedema.
Truhan AP
Am Fam Physician; 1985 May; 31(5):135-8. PubMed ID: 3993510
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
8. PARALLEL ASSAYS OF THYROTROPHIN, LONG-ACTING THYROID STIMULATOR AND EXOPHTHALMOS-PRODUCING SUBSTANCE IN ENDOCRINE EXOPHTHALMOS AND PRETIBIAL MYXEDEMA.
PIMSTONE BL; HOFFENBERG R; BLACK E
J Clin Endocrinol Metab; 1964 Oct; 24():976-82. PubMed ID: 14228536
[No Abstract] [Full Text] [Related]
9. [Clinical picture of pretibial myxedema and new aspects of diagnosis and pathogenesis].
Kind R; Hornstein OP
Hautarzt; 1976 Aug; 27(8):375-81. PubMed ID: 955898
[TBL] [Abstract][Full Text] [Related]
10. [Circumscribed pretibial myxedema--a case report of 5 cases and the detection of long-acting thyroid stimulator (LATS)].
Tagami H; Watanabe S; Nagata I; Katsuura Y; Fujii M
Hifuka Kiyo; 1966 Aug; 61(3):216-26. PubMed ID: 6008773
[No Abstract] [Full Text] [Related]
11. Pretibial myxedema: pathophysiology and treatment options.
Fatourechi V
Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic problems in thyroid diseases].
Höfer R; Schatz H
Z Gesamte Inn Med; 1969 Mar; 24(6):Suppl:91-6 c. PubMed ID: 5802036
[No Abstract] [Full Text] [Related]
13. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
14. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
Yamakido M; Yokoyama M; Noguchi S
Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
[No Abstract] [Full Text] [Related]
15. Graves' autoantibodies to extrathyroidal TSH receptor: their role in ophthalmopathy and pretibial myxedema.
Rotella CM; Alvarez F; Kohn LD; Toccafondi R
Acta Endocrinol Suppl (Copenh); 1987; 281():344-7. PubMed ID: 3475915
[No Abstract] [Full Text] [Related]
16. [Immunopathogenetic, endocrinologic and therapeutic problems of EMO syndrome. Observations based on a case report].
Göring HD; Ziemer A
Dermatol Monatsschr; 1989; 175(8):492-8. PubMed ID: 2792490
[TBL] [Abstract][Full Text] [Related]
17. The long-acting thyroid stimulator and thyroid disease.
Kriss JP
Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
[No Abstract] [Full Text] [Related]
18. Can LATS be detected by immunofluorescence?
Beall GN; Solomon DH; Doniach D; Roitt IM
J Clin Endocrinol Metab; 1969 Aug; 29(8):1114-6. PubMed ID: 4895860
[No Abstract] [Full Text] [Related]
19. Pretibial myxedema and nonthyrotoxic thyroid disease.
Lynch PJ; Maize JC; Sisson JC
Arch Dermatol; 1973 Jan; 107(1):107-11. PubMed ID: 4118738
[No Abstract] [Full Text] [Related]
20. [Pretibial circumscribed myxedema].
Témime P; Miller G
Bull Soc Fr Dermatol Syphiligr; 1968; 75(4):466-7. PubMed ID: 4883260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
